Related references
Note: Only part of the references are listed.Single- and Multiple-Ascending-Dose Studies of the NS3 Protease Inhibitor Asunaprevir in Subjects with or without Chronic Hepatitis C
Claudio Pasquinelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Resistance Analysis of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir
Fiona McPhee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Antiviral strategies in hepatitis C virus infection
Christoph Sarrazin et al.
JOURNAL OF HEPATOLOGY (2012)
Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
Anna S. Lok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Boceprevir: A Protease Inhibitor for the Treatment of Chronic Hepatitis C
Bryce S. Foote et al.
ANNALS OF PHARMACOTHERAPY (2011)
Syntheses and initial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus
Xiaofan Zheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Multiple Ascending Dose Study of BMS-790052, a Nonstructural Protein 5A Replication Complex Inhibitor, in Patients Infected with Hepatitis C Virus Genotype 1
Richard E. Nettles et al.
HEPATOLOGY (2011)
Genotypic and Phenotypic Analysis of Variants Resistant to Hepatitis C Virus Nonstructural Protein 5A Replication Complex Inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations
Robert A. Fridell et al.
HEPATOLOGY (2011)
Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric mice
Eiji Ohara et al.
JOURNAL OF HEPATOLOGY (2011)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
MK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A Protease
Nigel J. Liverton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Resistance Analysis of the Hepatitis C Virus NS5A Inhibitor BMS-790052 in an In Vitro Replicon System
Robert A. Fridell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435
Oliver Lenz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus
Ivan Gentile et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
New NS5B polymerase inhibitors for hepatitis C
Florence Legrand-Abravanel et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection
Christoph Sarrazin et al.
GASTROENTEROLOGY (2010)
Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs)
Tara L. Kieffer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Identification of Hepatitis C Virus NS5A Inhibitors
Julie A. Lemm et al.
JOURNAL OF VIROLOGY (2010)
Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
Edward J. Gane et al.
LANCET (2010)
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
Min Gao et al.
NATURE (2010)
Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding
Keith P. Romano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Development of novel antiviral therapies for hepatitis C virus
Kai Lin
VIROLOGICA SINICA (2010)
Selection and Characterization of Hepatitis C Virus Replicons Dually Resistant to the Polymerase and Protease Inhibitors HCV-796 and Boceprevir (SCH 503034)
Mike Flint et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors
Robert Chase et al.
ANTIVIRAL RESEARCH (2009)
New Therapies for Hepatitis C Virus Infection
Vincent Soriano et al.
CLINICAL INFECTIOUS DISEASES (2009)
HCV NS5B Polymerase Inhibitors
James R. Burton et al.
CLINICS IN LIVER DISEASE (2009)
Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues
Nathaniel A. Brown
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection
Pierre L. Beaulieu
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
HCV796: A Selective Nonstructural Protein 5B Polymerase Inhibitor with Potent Anti-Hepatitis C Virus Activity In Vitro, in Mice with Chimeric Human Livers, and in Humans Infected with Hepatitis C Virus
Norman M. Kneteman et al.
HEPATOLOGY (2009)
Characterization of Resistance to the Protease Inhibitor Boceprevir in Hepatitis C Virus-Infected Patients
Simone Susser et al.
HEPATOLOGY (2009)
Structural Basis for Resistance of the Genotype 2b Hepatitis C Virus NS5B Polymerase to Site A Non-Nucleoside Inhibitors
Edwin H. Rydberg et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Sequence variation of NS3 and NS4A in hepatitis C virus (HCV) replicons following exposure to ITMN-191 concentrations likely to encompass those achieved in human liver following clinical dosing
A. J. V. Thompson et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Crystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C Virus
Robert A. Love et al.
JOURNAL OF VIROLOGY (2009)
Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)
Scott D. Seiwert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Characterization of resistance mutations against HCV ketoamide protease inhibitors
Xiao Tong et al.
ANTIVIRAL RESEARCH (2008)
Future treatment options for HCV: Double, triple, what is the optimal combination?
Bernd Kronenberger et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2008)
Regulation of hepatitis C virion production via phosphorylation of the NS5A protein
Timothy L. Tellinghuisen et al.
PLOS PATHOGENS (2008)
The lipid droplet is an important organelle for hepatitis C virus production
Yusuke Miyanari et al.
NATURE CELL BIOLOGY (2007)
Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2′-C-methylcytidine
Claire Pierra et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus
Sophie Le Pogam et al.
JOURNAL OF VIROLOGY (2006)
VX-950, a novel hepatitis C virus (HCV) NS34A protease inhibitor, exhibits potent antiviral activities in HCV replicon cells
K Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase
G Kukolj et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase
TL Tellinghuisen et al.
NATURE (2005)
Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assay
DR O'Boyle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Global epidemiology of hepatitis C virus infection
CW Shepard et al.
LANCET INFECTIOUS DISEASES (2005)
Hepatitis C virus NS5A: tales of a promiscuous protein
A Macdonald et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitro
LJ Lu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
D Lamarre et al.
NATURE (2003)
Protein-protein interactions between hepatitis C virus nonstructural proteins
M Dimitrova et al.
JOURNAL OF VIROLOGY (2003)
Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex
D Egger et al.
JOURNAL OF VIROLOGY (2002)
Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity
Y Shirota et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Mutational analysis of the structure and functions of hepatitis C virus RNA-dependent RNA polymerase
WP Qin et al.
HEPATOLOGY (2001)
Efficient initiation of HCV RNA replication in cell culture
KJ Blight et al.
SCIENCE (2000)
Share Paper
